Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO)

CUSIP: 68621F102

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
-1,555,923
Put/Call ratio
91%
SEC-reported price per share
$3.20
Number of holders
119
Value change
-$4,632,565
Number of buys
58
Open additional details 1 more signal available
Number of sells
48
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
127,085,490

Security key

68621F102

Report period

Q4 2024

Institutions

119

Top holders

10

Ownership snapshot

Top reported holders of ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Albert Erani Family Trust...
Disclosed value leader
Albert Erani Family Trust...
Comparable rows
0/15
Latest evidence
27 Nov 2024
3/4/5 13F Highest disclosed value: $508,577,870 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Albert Erani Family Trust dated 12/29/2012 has the largest disclosed position value at $508.58M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Albert Erani Family Trust dated 12/29/2012's linked filing trail.
Disclosed position value Top 5
Albert Erani Family Trust dated 1... $508.58M
Dennis Erani $508.58M
Dennis Erani 2012 Issue Trust dat... $508.58M
RED Holdings, LLC $508.58M
2016 Organo 10-Year Grat U/a/d Se... $254.29M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Albert Erani Family Trust dated 12/29/2012
3/4/5
10%+ Owner
—
denominator unverified
$508,577,870
118,896,054 shares
— 28 Dec 2021
Dennis Erani
3/4/5
10%+ Owner
—
denominator unverified
$508,577,870
118,896,054 shares
— 15 Dec 2021
Dennis Erani 2012 Issue Trust dated 12/20/12
3/4/5
10%+ Owner
—
denominator unverified
$508,577,870
118,896,054 shares
— 15 Dec 2021
RED Holdings, LLC
3/4/5
10%+ Owner
—
denominator unverified
$508,577,870
118,896,054 shares
— 28 Dec 2021
2016 Organo 10-Year Grat U/a/d September 30 2016 Gn
3/4/5
10%+ Owner
—
denominator unverified
$254,288,935
59,448,027 shares
— 18 Nov 2021
GN 2016 Family Trust u/a/d August 12, 2016
3/4/5
10%+ Owner
—
denominator unverified
$207,253,480
51,085,403 shares
— 27 Nov 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
119
Shares
62,559,435
Rows available
119
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
111
Q4 2024 holders
119
Holder diff
8
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .